Vir Biotechnology and GSK Announce Start of NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19
December 17, 2020 16:01 ET
|
Vir Biotechnology, Inc.
– Randomized, placebo-controlled, multicenter, global Phase 3 trial will investigate the safety and efficacy of VIR-7831 in hospitalized adults with COVID-19 – SAN FRANCISCO and LONDON, Dec. 17,...
AAFA Praises U.S. House Passage of the FASTER Act
November 17, 2020 21:34 ET
|
Asthma and Allergy Foundation of America
Washington D.C., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Today the House of Representatives passed H.R. 2117. Named the Food Allergy Safety, Treatment, and Research Act, it is easier known as the FASTER...
Unissant Awarded $47.2 Million Data Services Contract to support U.S. Customs and Border Protection (CBP)
November 16, 2020 09:00 ET
|
Unissant, Inc.
HERNDON, Va., Nov. 16, 2020 (GLOBE NEWSWIRE) -- The Department of Homeland Security (DHS) has awarded Unissant a $47.2 million contract to provide Data and Meta Data Services for the Targeting and...
Unissant Awarded $182.3 Million Vetting Workflow Processing Services Contract to support U.S. Customs and Border Protection (CBP)
November 13, 2020 09:33 ET
|
Unissant, Inc.
HERNDON, Va., Nov. 13, 2020 (GLOBE NEWSWIRE) -- The Department of Homeland Security (DHS) has awarded Unissant a $182.3 million contract to provide Vetting Workflow Processing Services for the...
NIH Awards Prize to Hemex Health’s Non-Invasive Sickle Cell, Malaria, Anemia Rapid Test (“SMART”) Diagnostic Technology
October 26, 2020 08:00 ET
|
Hemex Health
PORTLAND, Ore., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Researchers from Hemex Health, Medtronic plc, Case Western Reserve University, and the University of Nebraska Medical Center’s International...
Provectus Biopharmaceuticals Announces Acceptance of PV-10® Pancreatic Cancer Abstract at 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 15, 2020 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that H. Lee Moffitt Cancer Center will present non-clinical data from ongoing research on investigational...
Renibus Therapeutics’ COVID-19 Treatment, RBT-9, Shows Antiviral Activity Against SARS-CoV-2 In Vitro
October 07, 2020 09:00 ET
|
Rénibus Therapeutics Inc.
DALLAS, Texas, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that its investigational treatment for COVID-19, RBT-9, has...
Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
October 06, 2020 15:30 ET
|
Ellume Health
VALENCIA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Ellume, the company reimagining digital diagnostics, today announced a $30 million Phase 2 award from the U.S. National Institutes of Health...
Provectus Biopharmaceuticals Completes Enrollment of PV-10® Study for Treatment of Symptomatic Neuroendocrine Tumors Metastatic to the Liver Refractory to Somatostatin Analogs and Peptide Receptor Radionuclide Therapy
October 05, 2020 08:00 ET
|
Provectus Biopharmaceuticals Inc.
Company plans to seek end-of-phase meeting with Australia’s Therapeutic Goods Administration in Q1 2021 KNOXVILLE, TN, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today...
BioAegis Therapeutics Announces Study Indicating Gelsolin Treatment Improves Survival and Reduces Lung Injury in Antibiotic Resistant Pneumonia
September 03, 2020 21:42 ET
|
BioAegis Therapeutics
MORRISTOWN, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious, inflammatory and degenerative diseases through...